1CM Inc (EPIC) AI Stock Analysis

• Market Cap: C$19.43M
• Dividend Yield: N/A
• Average Volume (3M): 106.00
• Price to Earnings (P/E): 10.4
• Beta (1Y): 1.54
• Revenue Growth: 34.71%
• EPS Growth: N/A
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 117,736,940
• 10 Day Avg. Volume: 200
• 30 Day Avg. Volume: 106
• PEG Ratio: -2.70
• Price to Book (P/B): 0.96
• Price to Sales (P/S): 0.38
• P/FCF Ratio: 11.03
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 54 Neutral
• Price Target: C$0.17 ▲(5.00% Upside)
• Action: Reiterated Date: 02/04/26
• Date: Action: Reiterated 02/04/26

The score is supported by strong recent revenue growth and a relatively low-leverage balance sheet, but is held back by compressed, very thin margins and weak free-cash-flow conversion. Technicals are also soft (negative MACD and below key longer-term moving averages), while valuation is not compelling given the ~33 P/E and lack of dividend support.

Positive Factors

Rapid revenue scaling

Sustained revenue growth of ~223% TTM signals successful commercial traction and expanding market reach. A larger revenue base provides durable optionality for operating leverage, funding for R&D or commercialization, and a platform to improve unit economics if growth is maintained.

Low leverage / strong liquidity buffer

Conservative leverage (debt-to-equity ~0.17) and relatively stable assets provide long-term financial flexibility. Low debt reduces refinancing and interest-rate risk, enabling durable investment in growth, M&A or R&D without forcing distressed capital raises in adverse conditions.

Positive operating cash flow

Positive operating cash flow (~$2.0M TTM) shows the underlying business can generate cash from operations after prior negative periods. This improves resilience, reduces near-term external financing dependence, and creates a foundation to strengthen FCF as reinvestment and working-capital cycles normalize.

Negative Factors

Very thin gross and net margins

Margins this thin leave the business highly exposed to input-cost volatility, pricing pressure, and any operational setbacks. Low gross and net margins constrain reinvestment capacity, limit buffer against downturns, and make sustained profitability sensitive to small adverse changes.

Weak free cash flow conversion

Profitability is not reliably translating into free cash: FCF is tiny and down ~76%, with FCF-to-net income around 0.10x. Persistent weak cash conversion limits self-funding of growth, increases dependency on external capital, and raises risk around sustaining investments and debt servicing.

Material margin compression vs prior year

Significant margin compression from ~19.5% to ~6.8% suggests structural pressures—product mix shifts, pricing erosion, or rising costs. Such deterioration undermines the durability of reported earnings and implies management must address cost structure or pricing to restore sustainable profitability.

1CM Inc Business Overview & Revenue Model

Company Description

1CM Inc. operates as a multidimensional cannabis company. It focuses on retail customers and technology to democratize cannabis markets. The company was formerly known as Leviathan Natural Products Inc. and changed its name to 1CM Inc. in September 2022. 1CM Inc. is based in Markham, Canada.

How the Company Makes Money

null

1CM Inc Financial Statement Overview

Summary

Revenue scaled sharply (~223% TTM), and the balance sheet is conservatively levered (debt-to-equity ~0.17). However, profitability is thin (TTM gross margin ~6.8%, net margin ~0.9%) with meaningful margin compression versus 2024, and cash flow quality is weak (free cash flow ~0.19M, down ~76%, with low FCF-to-net income ~0.10x).

Income Statement

TTM (Trailing-Twelve-Months) revenue is up strongly versus the prior annual period (revenue growth of ~223%), showing meaningful scale-up. Profitability, however, is thin: gross margin is ~6.8% and net margin is ~0.9% in TTM, and margins have compressed versus 2024 (gross margin ~19.5%, net margin ~1.1%). The company is profitable in the most recent periods, but the earnings profile remains low-margin and sensitive to cost pressures.

Balance Sheet

Leverage looks conservative in the latest period with debt-to-equity around ~0.17 in TTM and equity of ~$29.6M against ~$4.9M of debt, providing balance-sheet flexibility. Total assets are stable (~$42.8M TTM). Return on equity is modest (~2.2% TTM), indicating profitability is not yet translating into strong shareholder returns, but overall balance-sheet risk appears contained versus earlier years.

Cash Flow

Operating cash flow is positive in TTM (~$2.0M), but free cash flow is very light (~$0.19M) and down sharply (free cash flow growth ~-76%), suggesting higher reinvestment needs and/or weaker cash conversion. Free cash flow relative to net income is low (~0.10x), pointing to profits not consistently turning into durable free cash generation. This is an improvement from the historically negative cash flow periods, but recent cash flow quality is uneven.

Breakdown	Nov 2025	Nov 2024	Aug 2023	Nov 2022	Aug 2021
Income Statement
Total Revenue	73.37M	57.22M	35.34M	842.49K	341.81K
Gross Profit	6.65M	11.18M	7.61M	-428.00K	-148.00K
EBITDA	2.88M	2.86M	1.31M	-3.36M	-3.57M
Net Income	484.85K	615.91K	-914.00K	-4.73M	-4.56M
Balance Sheet
Total Assets	43.52M	39.87M	34.02M	28.23M	9.32M
Cash, Cash Equivalents and Short-Term Investments	6.15M	4.97M	3.08M	2.24M	162.46K
Total Debt	3.42M	7.85M	6.39M	11.13M	12.26M
Total Liabilities	14.65M	12.14M	9.42M	12.85M	13.78M
Stockholders Equity	28.87M	27.73M	24.60M	15.38M	-3.85M
Cash Flow
Free Cash Flow	2.51M	762.99K	-4.37M	-2.75M	-2.01M
Operating Cash Flow	2.71M	2.47M	-1.75M	-2.53M	-1.99M
Investing Cash Flow	-627.84K	-1.71M	1.33M	1.75M	-150.80K
Financing Cash Flow	-1.57M	1.13M	1.26M	2.85M	2.30M

1CM Inc Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.16
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:EPIC, the sentiment is Negative. The current price of 0.16 is below the 20-day moving average (MA) of 0.18, below the 50-day MA of 0.17, and below the 200-day MA of 0.25, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 45.44 is Neutral, neither overbought nor oversold. The STOCH value of 41.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:EPIC.

1CM Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ROMJ	55 Neutral	C$33.25M	3.70	7.78%	―	28.55%	―
EPIC	54 Neutral	C$19.43M	10.42	2.21%	―	34.71%	―
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
AVCN	46 Neutral	C$20.11M	-5.08	-68.32%	―	2.41%	74.61%
LABS	45 Neutral	C$27.35M	-3.68	-19.10%	―	18.06%	34.58%
PCLO	44 Neutral	C$10.77M	5.19	―	―	15.64%	58.47%
GWAY	41 Neutral	C$23.91M	-44.16	-2.15%	―	19.66%	84.34%

1CM Inc Corporate Events

1CM Inc. Promotes Antony Pramoth to Chief Financial Officer

1CM Inc. has appointed internal candidate Antony Pramoth as its new Chief Financial Officer, replacing former CFO Harshil Chovatiya with immediate effect. The promotion of Pramoth, who has been with the company since October 2023, signals a continuity-focused leadership transition in the finance function as 1CM pursues its strategy of expanding cash-flow positive cannabis and liquor retail locations through organic growth and acquisitions.

The most recent analyst rating on (TSE:EPIC) stock is a Hold with a C$0.17 price target. To see the full list of analyst forecasts on 1CM Inc stock, see the TSE:EPIC Stock Forecast page.

SNDL Closes First Tranche of Cannabis Store Acquisition from 1CM

SNDL Inc. has completed the acquisition of five cannabis retail stores in Alberta and Saskatchewan from 1CM Inc., marking the first closing under an amended arrangement agreement between the two companies. A second and final closing, covering an additional 27 cannabis retail stores in Ontario, is expected in the first half of 2026 pending regulatory approvals, positioning SNDL to further consolidate its presence in Canada’s cannabis retail market while allowing 1CM to recycle capital and focus on its broader growth strategy.

The most recent analyst rating on (TSE:EPIC) stock is a Hold with a C$0.17 price target. To see the full list of analyst forecasts on 1CM Inc stock, see the TSE:EPIC Stock Forecast page.